Novatek Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch Novatek Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive. (NCT05785390) | Novatek Pharmaceuticals | 2023-02-22 |
| To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants (NCT04914377) | Novatek Pharmaceuticals | 2021-06-08 |
Track Novatek Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.